World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02031497
Date of registration: 08/01/2014
Prospective Registration: No
Primary sponsor: Institute For European Expertise in Physiology
Public title: Comparison of the Effects of a 12-Week Consumption of Two Carbonated Beverages on Insulin Sensitivity SEDULC
Scientific title:
Date of first enrolment: October 2012
Target sample size: 60
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02031497
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Other. Masking: Triple (Participant, Care Provider, Investigator).  
Phase:  N/A
Countries of recruitment
France
Contacts
Name:     Fabrice Bonnet, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Centre Hospitalo-Universitaire de Rennes
Name:     Fabrice Lainé, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Centre Hospitalo-Universitaire de Rennes
Key inclusion & exclusion criteria

Inclusion Criteria:

- Healthy male or female

- Subject taking at least three main meals (breakfast, lunch, dinner)

- Subject able to understand and sign an informed consent

- Subject drinking and enjoying soft drinks

- Subject appreciating sweeteners taste

- 19 kg/m² < BMI< 30 kg/m²

Exclusion Criteria:

- Any severe or acute illness that may influence the results of the study or may be
life-threatening

- Pregnant or breastfeeding subject

- Past or present metabolic or digestive diseases, with the exception of a possible
appendectomy

- Diabetes or severe acute illness that may alter blood sugar

- Treatment that may interfere with glucose homeostasis

- Past or present kidney disease (renal failure, ... )

- Local or systemic medication that may change water status, metabolism and feeding
behavior

- Antiplatelet treatment

- Alcohol consumption = 3-4 glasses / day ( = 21 drinks / week )

- Sustained physical exercise (more than 4 hours per week)

- Subject adding sweeteners (tablets or powder) in their diet

- Subject drinking more than two cans of drinks with sweeteners / day

- Subject dieting to lose weight

- Subject unable or unwilling to consume 2 liters of fluid / day



Age minimum: 18 Years
Age maximum: 50 Years
Gender: All
Health Condition(s) or Problem(s) studied
Glucose Homeostasis
Intervention(s)
Dietary Supplement: Drink with sweeteners
Dietary Supplement: Drink without sweeteners
Primary Outcome(s)
Matsuda Insulin sensitivity Index [Time Frame: Before and after each of the two 12-week intervention period]
Secondary Outcome(s)
Physical activity [Time Frame: Before and after each of the two 12-week intervention period]
Disposition index defined as Insulin sensitivity x insulinogenic Index [Time Frame: Before and after each of the two 12-week intervention period]
Dietary intake [Time Frame: Before and after each of the two 12-week intervention period]
Insulinogenic Index defined as ? insulin 0-30 / ? glucose 0-30 [Time Frame: Before and after each of the two 12-week intervention period]
HOMA-IR Index defined as fasting Glycemia x fasting insulinemia/22.5 [Time Frame: Before and after each of the two 12-week intervention period]
Secondary ID(s)
2012EL0905SEDULC
120901-10
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history